Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Vintafolide

Email this page to a colleague

« Back to Dashboard

What is the drug development status for Vintafolide?

Vintafolide is an investigational drug.

There have been 9 clinical trials for Vintafolide. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1^st 2008.

The most common disease conditions in clinical trials are Neoplasms, Lung Neoplasms, and Breast Neoplasms. The leading clinical trial sponsors are Endocyte and [disabled in preview].

Summary for Vintafolide

US Patents	0
International Patents	0
US Patent Applications	94
WIPO Patent Applications	87
Japanese Patent Applications	27
Clinical Trial Progress	Phase 2 (2008-09-01)
Vendors	6

Recent Clinical Trials for Vintafolide

Title	Sponsor	Phase
Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)	Endocyte	Phase 2
A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)	Endocyte	Phase 1
A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)	Endocyte	Phase 1

See all Vintafolide clinical trials

Clinical Trial Summary for Vintafolide

Top disease conditions for Vintafolide

Top clinical trial sponsors for Vintafolide

See all Vintafolide clinical trials

US Patents for Vintafolide

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

McKesson

Moodys

McKinsey

Medtronic

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.